Skip to Content
IJERPHInternational Journal of Environmental Research and Public Health
  • Article
  • Open Access

25 September 2022

Impact of Social Isolation during the COVID-19 Pandemic on Mental Health, Substance Use, and Homelessness: Qualitative Interviews with Behavioral Health Providers

,
,
,
,
,
,
,
,
1
Centers for Disease Control and Prevention COVID-19 Emergency Response, 1600 Clifton Rd., Atlanta, GA 30329, USA
2
Oak Ridge Institute for Science and Education (ORISE) Fellow, Oak Ridge Associated Universities, 100 Orau Way, Oak Ridge, TN 37830, USA
3
National Healthcare for the Homeless Council, 604 Gallatin Ave, Nashville, TN 37206, USA
4
Oregon Health Authority, 500 Summer Street NE, Salem, OR 97301, USA

Abstract

The United States is experiencing a syndemic of homelessness, substance use disorder, and mental health conditions, which has been further exacerbated by the COVID-19 pandemic. Although it is expected that mitigation strategies will curb community transmission of COVID-19, the unintended consequences of social isolation on mental health and substance use are a growing public health concern. Awareness of changing mental health and substance use treatment needs due to the pandemic is critical to understanding what additional services and support are needed during and post-pandemic, particularly among people experiencing homelessness who have pre-existing serious mental illness or substance use disorder. To evaluate these effects and support our understanding of mental health and substance use outcomes of the COVID-19 pandemic, we conducted a qualitative study where behavioral health providers serving people experiencing homelessness described the impact of COVID-19 among their clients throughout the United States. Behavioral health providers shared that experiencing social isolation worsened mental health conditions and caused some people to return to substance use and fatally overdose. However, some changes initiated during the pandemic resulted in positive outcomes, such as increased client willingness to discuss mental health topics. Our findings provide additional evidence that the social isolation experienced during the pandemic has been detrimental to mental health and substance use outcomes, especially for people experiencing homelessness.

1. Introduction

The World Health Organization (WHO) declared coronavirus 2019 (COVID-19) a pandemic on 11 March 2020, after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread across the world [1,2]. To curb viral spread, community mitigation strategies like sheltering-in-place, mask mandates, and physical distancing became critical. These strategies resulted in unprecedented changes worldwide.
In addition to the COVID-19 pandemic, the United States has been experiencing a syndemic of homelessness, substance use disorder (SUD), and mental health conditions. In 2019, approximately 567,715 people were experiencing homelessness, 70,000 overdose deaths occurred, and 51.5 million people were experiencing mental illness [3,4,5]. Among people experiencing homelessness (PEH), roughly 20% reported severe mental illness and 15% reported chronic substance use [3].
Although vaccination and mitigation strategies will eventually curb community transmission of COVID-19, the unintended consequences of asking people to remain in isolation on mental health and substance use are a growing public health concern [6]. Since the onset of the COVID-19 pandemic, increases in anxiety, depression, and post-traumatic stress disorder have been reported globally [7,8]. A systematic, rapid review of the psychological impact of quarantine found that pandemic-related stressors might have long-lasting effects on well-being [9]. Social isolation, as a result of recommended COVID-19 mitigation strategies, has been associated with exacerbation of mental health challenges and overdose deaths [10,11,12]. People with SUD have disproportionately elevated rates of mental health challenges; those with a previous mental health diagnosis reported greater exacerbations of psychological symptoms during the pandemic than those who did not report previous diagnoses [12,13].
Awareness of changing mental health and substance use treatment needs due to the pandemic is critical to understanding what additional services and support are needed during and post-pandemic, particularly among PEH with pre-existing serious mental illness (SMI) and pre-existing SUD. The aim of this study was to describe behavioral health providers perceptions of mental health and substance use outcomes for PEH during the COVID-19 pandemic. To achieve this aim, we conducted a descriptive qualitative study with behavioral health providers across the United States.

2. Materials and Methods

2.1. Participants and Recruitment

Standardized, in-depth interviews were conducted from August 20 through 14 October 2020 with 50 behavioral health providers across the United States who provide services to clients experiencing homelessness who have SMI or SUD. Purposive sampling was used to identify study participants who routinely work with PEH and were from different geographic regions of the country. A study team from the Centers for Disease Control and Prevention (CDC) collaborated with the National Health Care for the Homeless Council (NHCHC) to identify and recruit potential participants. NHCHC distributed an invitation to participate in a qualitative research study to member organizations on an email listserv. Interested participants contacted the CDC study team, who then determined eligibility for participation. Those who worked in facilities serving PEH but were not directly involved in providing services to clients were excluded from participation; we sought to understand the perspectives of client-facing providers. Participants were provided a $100 gift card in appreciation for their time and participation.

2.2. Data Collection Tools and Procedures

CDC team members served as interviewers and notetakers. Interviewers and notetakers completed an internal training on qualitative data collection approaches and techniques prior to data collection. The two-hour training was conducted by a doctoral-level medical anthropologist and discussed the goals and paradigm in qualitative data collection, as well as technical best practices for conducting interviews and note taking.
Participants were invited to complete a brief Research Electronic Capture (REDCap) survey prior to or during the phone interview. The survey included questions about provider demographics and role and facility characteristics (staffing, client characteristics, and behavioral health services provided). Interviews were conducted by phone using a standardized, semi-structured interview developed by CDC, with input from NHCHC and behavioral health providers (Supplemental File S1). Each interview began with a review of participant rights; all were allowed to skip questions or withdraw at any point, the purpose of data collection and planned use and protection of data and personal data, and risks and benefits were explained. At the end of the consent script, interviewers asked for verbal indication of consent to participate, before asking permission to audio record the conversations.
On average, interviews took 45 min to complete, and covered topics such as changes to service provision during COVID-19, perspectives of changes to mental health and substance use among their clients, and about success and unintended benefits that emerged during COVID-19.

2.3. Data Analysis

Interviews were audio recorded and transcribed verbatim by CaptionSync, a transcription company. Transcripts were imported into MAXQDA, a qualitative data management software, for analysis [14]. Because the authors sought to describe the perspectives and experiences of participants without generating new theory, thematic analysis was conducted using Braun & Clarke’s six phase framework for analysis: (1) become familiar with the data (2) generate initial codes (3) search for themes (4) review themes (5) define themes (6) write-up themes [15]. The coding team reviewed interview transcripts and interview notes to become familiar with the data, and an a priori codebook was developed based on the interview guides and preliminary review of the data. Three members of the project team (AJ, AM, JB) each coded one transcript independently to assess consistent application of codes. The rest of the transcripts were coded independently by two of the three coders, with regular check-ins to discuss new codes that should be added or challenges determining code application. Codes were then grouped by topic to create themes, described in the results.

3. Results

Study Population

Table 1 describes characteristics of the 50 behavioral health providers from across all 10 Department of Health and Human Services’ regions in the United States. No participants withdrew their participation during or after their interview. Most participants were female (n = 42, 84%) and non-Hispanic White (n = 31, 62%). Behavioral health providers interviewed included case managers (n = 10), social workers (n = 8), therapists or counselors (n = 7), nurse or nurse practitioners (n = 6), outreach staff (n = 5), other behavioral health providers (n = 5), directors (n = 5), peer specialists (n = 3), and a psychiatrist or psychologist (n = 1) who provide behavioral health services including psychiatric or mental health evaluations, treatment, or referral; substance use evaluations, treatment, referral, provision of medications for opioid use disorder (MOUD); counseling; non-pharmacologic treatments; or substance use disorder-related services. All participants provided services to clients with a behavioral health-related diagnosis, 98% served PEH and clients with SUD, and 88% served clients with SMI. Since these conditions are intersectional, 96% of providers served PEH clients with SUD, 98% served PEH clients with a behavioral health diagnosis, and 88% served PEH clients with a SMI. Most of the participants worked in community health centers (n = 32, 64%), served on street outreach teams (n = 17, 34%), or delivered out-patient psychiatric services (n = 11, 22%).
Table 1. Behavioral Health Service Provider Participant Demographics and Clinic Characteristics, 20 August–14 October 2020.

4. Themes

4.1. The Negative Impacts of Social Isolation

The detrimental impact of social isolation emerged as a cross-cutting theme (Table 2). Providers expressed that prior to the COVID-19 pandemic, their clients depended on social connection, in-person services and groups, and access to resources to maintain recovery for their SUD or mental health condition. Social isolation was, “the worst thing for anybody with mental health or substance abuse” conditions. One provider noted that social isolation was a risk factor for their clients, “because the opposite of addiction is connection.” Providers reported some clients chose to risk COVID-19 exposure rather than stay isolated.
Table 2. Themes and Quotes from Behavioral Health Service Provider Interviews on Impact of Social Isolation during the COVID-19 Pandemic on Mental Health, Substance Use, and Homelessness, USA, 20 August–14 October 2020.
That’s probably the most prominent, the isolation. Some people would rather risk exposure than be isolated. That’s been pretty common across the board about most of the people I’ve talked to. One of the biggest issues they’re experiencing is the isolation, lack of community, and connection.
Social isolation had a largely negative, pervasive impact on the overall wellbeing of their clients and was a catalyst for negative outcomes, including return to substance use, increased substance use, fatal and non-fatal overdose, and an exacerbation of mental health symptoms.

4.2. Return to Substance Use and Increased Substance Use

Providers reported that people with SUDs who maintain abstinence in recovery thrive on a consistent routine of multi-faceted treatment, including group counseling, individual therapy, and MOUD (where appropriate). During the COVID-19 pandemic, social isolation led to a disruption of routine and structure, boredom, and lack of connection for many. Providers described that because social structures are embedded into many recovery-oriented programs, when this form of connection was no longer available, many clients experienced a dangerous catalyst toward returning to substance use. One provider pointed out,
They don’t have that interaction that they had before. Before we had COVID-19, we had medication assisted treatment, as well as groups, and more access physically to their counselor. So that one-two combination, it’s proven successful in helping people in their recovery. They don’t have that now.
Providers reported feeling the impact of recovery support groups such as Alcoholics Anonymous (AA) or Narcotics Anonymous (NA), was lessened as they moved online, and reported that many of their clients did not like the virtual format. Providers also reported the importance of facilitating groups in-person because they could better assess how their clients were doing, and felt their clients enjoyed connecting with others who were also in treatment and were positively influenced by others also in recovery.
Providers reported that social isolation fueled chaotic, increased use of substances among clients. The pandemic magnified many of the issues that providers reported their clients experienced, including mental illness, SUD, and homelessness. One provider described,
I think that relapse is a big thing. You spend 10 years of doing a specific drug, or way of life or living or several drugs, and then trying to get off and then based off of the world shifting in such, what I call madness, it kind of gives you a reason to relapse and go backwards. So that’s been a big issue with relapsing. It’s an up and down and up and down thing, stronger than it already has been because our clients are facing homelessness, addiction, and mental health. So, relapse is a big thing, and out here on the streets, drugs are, clearly they’re here. But I feel like a wave of more [drugs] have come in, so it’s been kind of chaotic.
Providers shared that their clients reported the pandemic and subsequent social isolation made them feel “out of control”, which led to increased substance use. Additionally, the instability of the COVID-19 pandemic caused clients to report purchasing more drugs than usual, out of concern they may not have access again. Because of this, “people are tending to use in a little bit more risky way than they had been,” increasing the likelihood of overdose.

4.3. Changes in Overdose Risk and Rates

Providers reported that clients with SUD who returned to substance use had to decide whether to use substances alone or risk contracting COVID-19 by using with others. One provider noted that “being alone, more people have overdosed” and “the messaging about need[ing] to isolate didn’t do a good job of taking the risks involved into account.” Isolation goes against the harm reduction strategy to ‘never use alone’ to reduce the risk of a fatal overdose. Another provider shared that using alone “is the exact opposite of what we need for an opioid epidemic.” As a result, providers described how social isolation could lead to fatal consequences. A provider shared,
I think people are using more substances. I think they’re using alone. We have an increase of I think 50% more deaths in the homeless population due to overdosing. So there’s been some things that have been available to them that they never had before, and I think they’re also suffering in ways that they weren’t before.
Another provider noted that more of their clients had died of overdose, whereas they did not know of any who died from COVID-19.

4.4. Access to Medications for Opioid Use Disorder (MOUD)

Providers and harm reductionists have advocated for greater access to MOUD, which treats opioid use disorder by preventing withdrawal symptoms and reducing cravings. During the COVID-19 pandemic, clinics and group sessions were closed, and some providers noted concern about maintaining client’s access to MOUD. Recognizing the need for ensuring access to medications, the Substance Abuse and Mental Health Services Administration (SAMHSA) posted COVID-19 guidance providing flexibility for allowing programs to offer MOUD for extended periods, ensuring that patients could access their prescriptions. Programs were also able to initiate buprenorphine treatment using telehealth and were able to see new patients without the usual requirement for an initial face-to-face visit, potentially lowering barriers to access. Providers considered this one of the positive impacts that the COVID-19 pandemic has had on their clients. However, they also noted it was not a perfect solution as providers were not evaluating their clients in-person as often to assess for signs of return to substance use.
I think it’s the way we would provide medically assisted treatment in a shared medical visit setting. So, it would be in a group setting and we would kind of do a group accountability with a multi-disciplinary team. We’re not doing that anymore, so a lot of our patients are relapsing because they don’t have the social support component of the group modality. So that’s been really difficult for our patients. Although it’s increase[d] accessibility to Buprenorphine, it’s decreased the support services around it, so a lot more patients are relapsing.
Providers reported that people receiving treatment for opioid use disorder benefit from a multi-modal approach, including support in group or individual therapy, or having a behavioral health provider to manage their care and treatment in addition to taking MOUD. Overall, however, providers described that they would like to see the reduced barriers to MOUD continue in the future.

4.5. Exacerbation of Mental Illness

Providers reported that the onset of the COVID-19 pandemic triggered anxiety, fear, depression, and stress in their clients. Subsequent social isolation due to stay-at-home orders detrimentally impacted client’s mental status because of the choice between staying home, which could exacerbate depression, or risking exposure by connecting with community. One provider shared, “if you have a serious mental illness, [isolation] seems to magnify whatever illness that person struggles with—depression, anxiety, psychosis—isolation is really detrimental.” For clients who had SMI, providers indicated paranoia as a common experience during the COVID-19 pandemic. One provider shared that among their clients,
There’s a lot of skepticism, paranoia, [and] delusions. And so, there’s a lot of delusions all the time about being watched, or being targeted, or like the government is watching, or they’re listening, kind of things like that. And so, something like this really, really kicked that into high gear for a lot of clients.
For clients experiencing unsheltered homelessness who were diagnosed with an SMI, feelings of paranoia intensified with the onset of COVID-19. PEH with SMI shared with providers that they felt that the pandemic was targeted against them “because they don’t want us around anymore.” Feelings of paranoia were especially pronounced when clients were being placed in emergency shelters and hotels, which were set up as protective housing or quarantine isolation sites. One provider described clients’ feelings of paranoia in the beginning of the pandemic while facilitating emergency sheltering:
There has been such a feeling of fear and apprehension and mistrust that we’ve had to overcome to really let people know that we’re just here to try to take care of them. When the pandemic first—I’m thinking back to April and May [2020], we had the National Guard here with us at our emergency shelter and the hotel. And they were very helpful. But there was a great deal of fear seeing these soldiers at our sites. And I had people who were homeless tell me that they thought that we, meaning the service providers, were going to lock them all up in a concentration camp.
However, providers described that the pandemic has sparked some positive change related to mental health outcomes. Providers described that more people than ever were reaching out for mental health support and that the COVID-19 pandemic had been the reason for people to seek help who may not have been willing to do so previously. Behavioral health providers noted that even though mental health was a stigmatized topic, more people were willing to talk about it because of COVID-19 and the many ways this experience has impacted their daily lives. Discussing mental health in general became more accepted and understood, and the conversations surrounding the impact of COVID-19 and isolation on mental health and substance use have become less stigmatized.

4.6. Navigating Homelessness While Experiencing Mental Illness or Substance Use Disorder

Providers had to navigate new COVID-19 restrictions for their clients experiencing homelessness, including restrictions that increased the difficulty of accessing limited shelter beds. Mitigation measures, including testing requirements, were very stressful for PEH. The additional stress of not being able to have a place to sleep without proof of a negative test, exacerbated feelings of depression.
Some shelters started requiring that people got a COVID test or they couldn’t come back to the shelter. And that was really stressful for some because they didn’t know where to get the test. And they were so stressed out because they had nowhere to go. We had a guy crying in our lobby. He said, “I’m too old for this. I can’t stay on the street. I’m too old. And none of the shelters will take me back because I haven’t had the COVID test.” And he was just really, really depressed and distraught.
Providers reported that the combined experience of homelessness and the emergence of a new, highly contagious virus was overwhelming, distressing, and confusing. For clients with a recent history of experiencing homelessness who were able to obtain housing, the transition into housing was made even more difficult by social isolation. One provider described “the socialness of homelessness” and how the new quietness of living alone exacerbated social isolation. Providers reported that their “housed clients are doing a better job of social distancing, but then experiencing higher levels of isolation, boredom, and depression”, which made it difficult for clients to cope with shelter-in-place orders. One provider noted feeling more worried about newly housed clients than sheltered clients,
Because it’s different. Even if the sheltered life is not the best life, you have distractions, you have other people around that are friends, you have social things that you see, you have interactions with people. And when you’re alone, you’re just kind of alone with your thoughts and to think about things and reflecting on your life and look around and say like, “I have this thing I always wanted, but I just feel so alone because I’ve lived in this environment where there was always some kind of stimulation going on, and now I don’t have anything.” What do I do with that?
Providers noted positive outcomes of the pandemic on homelessness, including the use of hotels as emergency shelters and “a small percent [of street homeless] were able to get in some temporary housing that would not have happened without COVID-19”. For another provider, they noted that one client’s mental health was positively impacted “because she was able to get into housing so quickly during this time”. Although some clients experienced reduced barriers to housing, there were also several that experienced increased barriers due to COVID-19 because landlords did not want to show apartments or their housing voucher expired. Although the use of hotels for emergency sheltering was temporary, it showed that solutions to combating the homelessness epidemic were possible.

5. Discussion

Understanding the mental health and substance use effects of the COVID-19 pandemic is critical to identify where future resources and interventions are needed to provide support. Behavioral health providers have unique knowledge of and expertise in the lived experiences of their clients, and the impact of homelessness, along with behavioral conditions like SUD and mental illness during the COVID-19 pandemic. These providers are most apt to discern changes among their clients and understand the impact of social isolation. Enhancing understanding of the unintended consequences of COVID-19 mitigation strategies seen by providers among their clients may help inform future public health interventions, policies and track long-term effects of the COVID-19 pandemic.

Themes and Major Takeaways

Several important themes emerged from these interviews, including the far-reaching impact of COVID-19 mitigation measures and social isolation, which led to return to and increased substance use and overdoses. Prior to the COVID-19 pandemic, the United States was experiencing an opioid epidemic [16]. During the COVID-19 pandemic, research has demonstrated that COVID-19 related social isolation and the stress of living in a pandemic are correlated with return to use, increased substance use, and reduced access to SUD treatment services [17,18]. In fact, overdoses reached a record high and acceleration during the pandemic, with a 30.5% increase in the United States in 2020 according to provisional estimates as of 25 August 2021 [19].
The COVID-19 pandemic has also exacerbated feelings of depression, anxiety, and loneliness amidst social isolation. This finding is supported by previous research that COVID-19 mitigation measures, and subsequent effects of those measures including social isolation, may lead to mental health symptoms, loneliness, and psychological trauma [17]. Furthermore, the compounded stress of homelessness during the pandemic further contributed to worsening mental health symptoms with increased feelings of stress, anxiety, and depression for PEH. Behavioral health providers shared that experiencing social isolation worsened mental health conditions and caused some people to return to substance use and fatally overdose. Maintaining open, low-barrier, and equitable access to MOUD during emergencies and ensuring people have regular access to mental health and SUD services during and post-COVID-19 pandemic are necessary. It will continue to be important to assess the impact on substance use even after the COVID-19 pandemic ends. Moving forward, we need to work to maintain as many of the benefits of transitioning services to a virtual environment (e.g., greater reach for therapeutic options and an increased availability of MOUD) as possible while addressing social isolation, and the consequences that come with it.
Our findings also highlight the importance of social connection for individuals in treatment for SUDs. According to a study by Petterson et al. (2020) the United States may experience a projected 75,000 “deaths of despair” due to the isolation and stress caused by the COVID-19 pandemic and warn that if the United States does not begin to implement solutions to the nation’s isolation, pain, and suffering due to COVID-19, then there will be a surge in preventable deaths due to drugs, alcohol, and suicide [20]. This is an opportunity to strategically and universally address the syndemic of homelessness, substance use disorder, and mental health conditions that has combated the United States for years and have increased during the COVID-19 pandemic, while also creating a public health approach to improving mental and emotional well-being. Additionally, as mentioned above, during the COVID-19 pandemic progress was made to secure housing placements for PEH to allow for social distancing. Future work needs to ensure that a sense of community can be maintained even when individuals are transitioned into individual housing opportunities.
The primary limitation of this study was that all interviews were conducted with behavioral health service providers and not directly with clients. Providers have different backgrounds, positions, and caseloads, which may have potentially impacted their perspectives and may not have captured the full breadth of their clients’ experiences during the pandemic. However, providers working with populations disproportionately affected by the pandemic not only have insight into experiences reported by their individual clients, but also offer a broad lens to the issues experienced by the range of clients they serve. Obtaining firsthand information regarding the lived experience of clients is an important next step to complement the data presented here. Additionally, although our sample included providers serving in various behavioral health roles, there was variance in how COVID-19 was being handled across agencies and within regions, impacted by funding and specific policies. Therefore, the findings presented here might not be representative of all experiences across the United States, particularly in rural communities. However, the strengths of this study outweigh these limitations because to our knowledge, it is the first national study of its kind. The findings capture the realities of being a behavioral health provider among disproportionately affected populations amidst the COVID-19 pandemic. This study’s findings provide a basis of what is needed to mitigate the consequences of COVID-19 among these populations.
Additionally, there are methodological limitations of this study. The study team did not calculate or assess quantitative measurement of inter-coder agreement, which could limit the reliability of our results. However, because there were so few coders using a pre-established set of codes who met frequently, it is likely that the exploration of providers’ perceptions and experiences are still descriptive of their true experiences. These themes were also not assessed in light of existing theories, which could impact their transferability to other studies. Despite these limitations, this descriptive, exploratory study offers critical insight to the experiences and perspectives of a critical group of the healthcare and public health workforce.

6. Conclusions

Our findings provide additional evidence that the unintended consequences of COVID-19 mitigation strategies, namely social isolation, experienced during the pandemic has been detrimental to mental health and substance use outcomes, especially for PEH. Accessible supportive services for mental health and SUD are critical during emergencies. Furthermore, similar to tracking COVID-19 infections, mental health and substance use disorders need to be measured and disaggregated among demographic and regional categories during emergencies to ensure adequate support and inform interventions.
Mitigating the long-term effects of the pandemic on disproportionately affected populations, particularly people who are experiencing homelessness, substance use, and serious mental illness, requires a strategic, multi-faceted approach via policy, collaborative cross-disciplinary health professionals, and the public. Even after the threat of acquiring COVID-19 subsides, the impact of social isolation on mental health and substance use will continue to be a pervasive issue requiring tailored strategies for PEH and those with SMI or SUD.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijerph191912120/s1, File S1. Impact of Social Isolation During the COVID-19 Pandemic on Mental Health, Substance Use, and Homelessness: Interview Guide.

Author Contributions

Conceptualization, A.B., B.D. (Barbara DiPietro), M.C., M.Y., R.M., E.M., M.P.M., R.L.L. and A.A.M.; Methodology, A.A.M., A.J., C.H.C. and R.L.L.; Software, C.H.C., A.A.M., A.J. and J.B.; Data collection: A.A., M.P.M., A.J., C.M.R., V.L.F., L.R., S.C., A.C., J.V.V., G.B., R.L.L., R.M., B.D. (Brandi Dupervil) and C.H.C.; Formal Analysis, C.H.C., A.A.M., A.J. and J.B.; Writing—Original Draft Preparation, A.J.; Writing—Review and Editing, All authors.; Supervision, R.M. and E.M.; Project Administration, E.M., M.P.M. and R.M. All authors have read and agreed to the published version of the manuscript.

Funding

Funding for participant gift cards was provided by National Health Care for the Homeless Council.

Institutional Review Board Statement

This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy. See, e.g., 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. §241(d); 5 U.S.C. §552a; 44 U.S.C. §3501 et seq.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy reasons.

Conflicts of Interest

The authors declare no conflict of interest. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

References

  1. World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed on 2 June 2021).
  2. Cucinotta, D.; Vanelli, M. WHO Declares COVID-19 a Pandemic. Acta Biomed 2020, 91, 157–160. [Google Scholar] [CrossRef] [PubMed]
  3. U.S. Department of Housing and Urban Development. HUD 2019 Continuum of Care Homeless Assistance Programs Homeless Populations and Subpopulations. 2019. Available online: https://files.hudexchange.info/reports/published/CoC_PopSub_NatlTerrDC_2019.pdf (accessed on 18 August 2020).
  4. Centers for Disease Control and Prevention. Drug Overdose Deaths. Available online: https://www.cdc.gov/drugoverdose/deaths/index.html (accessed on 2 June 2021).
  5. National Alliance on Mental Illness. Mental Health by the Numbers. Available online: https://nami.org/mhstats (accessed on 2 June 2021).
  6. Banerjee, D.; Rai, M. Social Isolation in Covid-19: The Impact of Loneliness. Int. J. Soc. Psychiatry 2020, 66, 525–527. [Google Scholar] [CrossRef] [PubMed]
  7. Xiong, J.; Lipsitz, O.; Nasri, F.; Lui, L.M.W.; Gill, H.; Phan, L.; Chen-Li, D.; Iacobucci, M.; Ho, R.; Majeed, A.; et al. Impact of COVID-19 Pandemic on Mental Health in the General Population: A Systematic Review. J. Affect. Disord. 2020, 277, 55–64. [Google Scholar] [CrossRef] [PubMed]
  8. Bryant-Genevier, J.; Rao, C.Y.; Lopes-Cardozo, B.; Kone, A.; Rose, C.; Thomas, I.; Orquiola, D.; Lynfield, R.; Shah, D.; Freeman, L.; et al. Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic—United States, March–April 2021. MMWR Morb. Mortal. Wkly Rep. 2021, 70, 947–952. [Google Scholar] [CrossRef] [PubMed]
  9. Brooks, S.K.; Webster, R.K.; Smith, L.E.; Woodland, L.; Wessely, S.; Greenberg, N.; Rubin, G.J. The Psychological Impact of Quarantine and How to Reduce It: Rapid Review of the Evidence. Lancet 2020, 395, 912–920. [Google Scholar] [CrossRef]
  10. Henry, B.F.; Mandavia, A.D.; Paschen-Wolff, M.M.; Hunt, T.; Humensky, J.L.; Wu, E.; Pincus, H.A.; Nunes, E.V.; Levin, F.R.; El-Bassel, N. COVID-19, Mental Health, and Opioid Use Disorder: Old and New Public Health Crises Intertwine. Psychol. Trauma: Theory Res. Pract. Policy 2020, 12, S111–S112. [Google Scholar] [CrossRef] [PubMed]
  11. Czeisler, M.É.; Lane, R.I.; Petrosky, E.; Wiley, J.F.; Christensen, A.; Njai, R.; Weaver, M.D.; Robbins, R.; Facer-Childs, E.R.; Barger, L.K.; et al. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic—United States, June 24–30, 2020. MMWR Morb. Mortal. Wkly Rep. 2020, 69, 1049–1057. [Google Scholar] [CrossRef] [PubMed]
  12. Volkow, N.D. Collision of the COVID-19 and Addiction Epidemics. Ann. Intern. Med. 2020, 173, 61–62. [Google Scholar] [CrossRef] [PubMed]
  13. Columb, D.; Hussain, R.; O’Gara, C. Addiction Psychiatry and COVID-19: Impact on Patients and Service Provision. Ir. J. Psychol. Med. 2020, 37, 164–168. [Google Scholar] [CrossRef] [PubMed]
  14. VERBI. MAXQDA 2020 (Version 20.0.7); VERBI Software: Berlin, Germany, 2019. [Google Scholar]
  15. Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef]
  16. Centers for Disease Control and Prevention. CDC Grand Rounds: Prescription Drug Overdoses—A U.S. Epidemic. MMWR Morb. Mortal. Wkly Rep. 2012, 61, 10–13. Available online: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm?s_cid=mm6101a3_w (accessed on 3 June 2021).
  17. Jemberie, W.B.; Stewart Williams, J.; Eriksson, M.; Gronlund, A.; Ng, N.; Blom Nilsson, M.; Padyab, M.; Priest, K.C.; Sandlund, M.; Snellman, F.; et al. Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions. Front. Psychiatry 2020, 11, 714. [Google Scholar] [CrossRef] [PubMed]
  18. Silva, M.J.; Kelly, Z. The Escalation of the Opioid Epidemic Due to COVID-19 and Resulting Lessons About Treatment Alternatives. Am. J. Manag. Care 2020, 26, e202–e204. [Google Scholar] [CrossRef] [PubMed]
  19. Ahmad, F.B.; Cisewski, J.A.; Rossen, L.M.; Sutton, P. Provisional Drug Overdose Death Counts. National Center for Health Statistics. 2021. Available online: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation (accessed on 2 June 2021).
  20. Petterson, S.; Westfall, J.M.; Miller, B.F. Projected Deaths of Despair from COVID-19. 2020. Available online: https://wellbeingtrust.org/wp-content/uploads/2020/05/WBT_Deaths-of-Despair_COVID-19-FINAL-FINAL.pdf (accessed on 11 June 2021).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.